2018
The “mortality ascent”
Herrera-Escobar JP, Rios-Diaz AJ, Zogg CK, Wolf LL, Harlow A, Schneider EB, Cooper Z, Ordonez CA, Salim A, Haider AH. The “mortality ascent”. Journal Of Trauma And Acute Care Surgery 2018, 84: 139-145. PMID: 28930947, DOI: 10.1097/ta.0000000000001706.Peer-Reviewed Original ResearchConceptsUnstable trauma patientsLevel I TCsLevel II TCsHours postadmissionTrauma patientsLevel ILevel IIMortality riskHospital mortalityLog-binomial regression modelsNational Trauma Data BankComparable mortality riskHospital-level confoundersInjury Severity ScoreSystolic blood pressureAvailable treatment modalitiesTrauma Data BankSpecific risk factorsRisk-adjusted modelsBlood pressureHigher relative mortalityUnstable patientsBurn patientsSeverity scoreTreatment modalities
2017
Epidemiology of malignant cutaneous granular cell tumors: A US population-based cohort analysis using the Surveillance, Epidemiology, and End Results (SEER) database
Mirza FN, Tuggle CT, Zogg CK, Mirza HN, Narayan D. Epidemiology of malignant cutaneous granular cell tumors: A US population-based cohort analysis using the Surveillance, Epidemiology, and End Results (SEER) database. Journal Of The American Academy Of Dermatology 2017, 78: 490-497.e1. PMID: 28989104, PMCID: PMC5815907, DOI: 10.1016/j.jaad.2017.09.062.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overBlack or African AmericanChildFemaleGranular Cell TumorHumansIncidenceKaplan-Meier EstimateKidney NeoplasmsMaleMiddle AgedNeoplasm StagingPancreatic NeoplasmsResidence CharacteristicsRetrospective StudiesSEER ProgramSex FactorsSkin NeoplasmsSurvival RateUnited StatesWhite PeopleYoung AdultConceptsDisease-specific survivalCutaneous granular cell tumorsPopulation-based cohort analysisEnd Results (SEER) databaseMedian survival timeGranular cell tumorSurgical resectionResults databaseCell tumorsCohort analysisSurvival timeCox proportional hazards regressionPoor disease-specific survivalRisk-adjusted associationHigh-risk patientsEnd Results (SEER) dataProportional hazards regressionSingle-institution studyAdvanced cancer stageRisk-adjusted modelsDSS ratesOverall survivalPatient characteristicsSubstantial morbiditySecondary malignancies